The trademark application NGM BIOPHARMACEUTICALS was filed by NGM Biopharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 22, 2022, and it was registered by office on March 1, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations.
The mark was filed in class 42 with Providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
The mark was filed in class 44 with Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases.